Roche's Genentech launches DTC program amid Trump's MFN directive
2025-10-16 12:18:38 ET
More on Roche Holding
- Roche's Giredestrant: A Ray Of Hope On A Cloudy Horizon?
- Roche Holding AG (RHHBY) Discusses On Pharma Day 2025 (Transcript)
- Roche Holding AG (RHHBY) Special Call - Slideshow
- Roche, Eli Lilly Alzheimer's blood diagnostic test wins FDA approval
- Roche's Genentech gets FDA nod for lung cancer treatment
Read the full article on Seeking Alpha
For further details see:
Roche’s Genentech launches DTC program amid Trump’s MFN directiveNASDAQ: SGIOF
SGIOF Trading
0.0% G/L:
$23.105 Last:
800 Volume:
$25.373 Open:


